Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Longley

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
The FEBS Journal|August 7, 2023
Editor Profile: Daniel Longley, Daniel B Longley
The FEBS Journal|May 29, 2018
FLIP as a therapeutic target in cancerLuke Humphreys, Margarita Espona-Fiedler, Daniel B Longley
Cell Death and Differentiation|December 16, 2021
The role of Ubiquitination in Apoptosis and NecroptosisJamie Z Roberts, Nyree Crawford, Daniel B Longley
Clinical Colorectal Cancer|March 7, 2003
Predictive markers for colorectal cancer: current status and future prospectsDaniel B Longley, Ultan McDermott, Patrick G Johnston
Nature Reviews. Cancer|May 2, 2003
5-fluorouracil: mechanisms of action and clinical strategiesDaniel B Longley, D Paul Harkin, Patrick G Johnston
Biochimica Et Biophysica Acta|September 16, 2006
Drug resistance, predictive markers and pharmacogenomics in colorectal cancerDaniel B Longley, Wendy L Allen, Patrick G Johnston
The FEBS Journal|February 26, 2020
FLIP(L): the pseudo-caspasePeter Smyth, Tamas Sessler, Christopher J Scott, et al.
Pharmacology & Therapeutics|June 26, 2020
The Multiple Roles of the IAP Super-family in cancerSwati Kumar, Ciaran Fairmichael, Daniel B Longley, et al.
Nature Reviews. Cancer|September 25, 2013
Cancer drug resistance: an evolving paradigmCaitriona Holohan, Sandra Van Schaeybroeck, Daniel B Longley, et al.
Cancers|March 25, 2022
Correction: Hamilton et al. Therapeutics Targeting the Core Apoptotic Machinery. <i>Cancers</i> 2021, <i>13</i>, 2618Claudia Hamilton, Jennifer P Fox, Daniel B Longley, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
The FEBS Journal|August 7, 2023
Editor Profile: Daniel Longley, Daniel B Longley
The FEBS Journal|May 29, 2018
FLIP as a therapeutic target in cancerLuke Humphreys, Margarita Espona-Fiedler, Daniel B Longley
Cell Death and Differentiation|December 16, 2021
The role of Ubiquitination in Apoptosis and NecroptosisJamie Z Roberts, Nyree Crawford, Daniel B Longley
Clinical Colorectal Cancer|March 7, 2003
Predictive markers for colorectal cancer: current status and future prospectsDaniel B Longley, Ultan McDermott, Patrick G Johnston
Nature Reviews. Cancer|May 2, 2003
5-fluorouracil: mechanisms of action and clinical strategiesDaniel B Longley, D Paul Harkin, Patrick G Johnston
Biochimica Et Biophysica Acta|September 16, 2006
Drug resistance, predictive markers and pharmacogenomics in colorectal cancerDaniel B Longley, Wendy L Allen, Patrick G Johnston
The FEBS Journal|February 26, 2020
FLIP(L): the pseudo-caspasePeter Smyth, Tamas Sessler, Christopher J Scott, et al.
Pharmacology & Therapeutics|June 26, 2020
The Multiple Roles of the IAP Super-family in cancerSwati Kumar, Ciaran Fairmichael, Daniel B Longley, et al.
Nature Reviews. Cancer|September 25, 2013
Cancer drug resistance: an evolving paradigmCaitriona Holohan, Sandra Van Schaeybroeck, Daniel B Longley, et al.
Cancers|March 25, 2022
Correction: Hamilton et al. Therapeutics Targeting the Core Apoptotic Machinery. <i>Cancers</i> 2021, <i>13</i>, 2618Claudia Hamilton, Jennifer P Fox, Daniel B Longley, et al.
Pageof 12